Healthcare

• Counter-drone, quantum-navigation and medical technologies are expanding the company's defence pipeline

PharmX Technologies (ASX: PHX) gives investors exposure to pharmacy ordering, electronic invoicing and transaction infrastructure. The central issue is whether recent operational progress can become a repeatableEarningspattern. That requires more than an attractive market theme: management must convert customerDemandinto revenue, protect margins and fund …

Mach7 Technologies (ASX: M7T) gives investors exposure to enterprise imaging software,Recurring Revenueand hospital contracts. The central issue is whether recent operational progress can become a repeatableEarningspattern. That requires more than an attractive market theme: management must convert customerDemandinto revenue, protect margins and fund growth …

Visionflex Group (ASX: VFX) is a small-cap Australian telehealth and remote-diagnostics hardware and software company that has spent the past year trying to shift itsBusinessmodel from lumpy, one-off hardware sales toward recurring, subscription-based revenue. The strategy is starting to show early traction: annualRecurring Revenueclimbed …

The Sydney clinic fit-out has been finalised, with four treatment rooms fully furnished and equipped. Emyria has recruited and trained approximately 20 Sydney-based therapists and four psychiatrists ahead of the launch. Two of those psychiatrists have received Authorised Prescriber endorsement from Australia'sTherapeutic Goods Administration(TGA), …

Starpharma Holdings (ASX: SPL) has quietly become one of the ASX's more dramatic healthcare re-rating stories.

Avecho Biotechnology (ASX: AVE) has become one of the more talked-about micro-cap names on the ASX health board in 2026, and the reason is straightforward: a small drug-delivery specialist has moved from the laboratory bench toward late-stage clinical data. For a company that has …